Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02078609
Title A Safety and Efficacy Study of LGH447 in Patients With Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult
Covered Countries USA | NLD | ITA | FRA | DEU | AUS

Facility Status City State Zip Country Details
Novartis Investigative Site Ann Arbor Michigan 48109 United States Details
Novartis Investigative Site Prahran Victoria 3181 Australia Details
Novartis Investigative Site Marseille 13273 France Details
Novartis Investigative Site Ulm 89081 Germany Details
Novartis Investigative Site Milano MI 20132 Italy Details
Novartis Investigative Site Milano MI 20162 Italy Details
Novartis Investigative Site Roma RM 00133 Italy Details
Novartis Investigative Site Shinagawa ku Tokyo 141 8625 Japan Details
Novartis Investigative Site Amsterdam 1081 HV Netherlands Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field